Introduction
============

Tuberculosis (TB) remains a leading cause of morbidity and mortality among communicable diseases, and it is currently ranked the major killer among worldwide infectious diseases caused by a single pathogen^[1](#fn01){ref-type="fn"}^. The HIV/AIDS pandemic, the deterioration of public health systems in developing countries and the emergence of multi (MDR), extensively (XDR), and totally (TDR) drug--resistance strains have further contributed to the spread of the pathogen and reinforced the urgent need for more efficient vaccines and treatment against TB ([@B28]). Moreover, latently infected people represent a dangerous reservoir of TB ([@B24]). The human population is estimated at approximately 7 billion by the United Nations, with over one third being infected with the tubercle bacilli. Therefore, it can be assumed that more than 2 billion people have latent TB infection (LTBI). Based on this statistics it is not unusual that understanding and controlling LTBI were considered as core parts of the End TB Strategy, launched from 2016 to 2035 by WHO ([@B24]).

Cholesterol has been identified as an essential carbon source for LTBI in which the bacteria exist in a non-replicative state termed dormancy ([@B41]). Several studies have demonstrated that *Mycobacterium tuberculosis* mutants lacking the capacity to acquire or degrade cholesterol are defective for growth in some animal models of TB ([@B44]; [@B11]; [@B41]). Furthermore it has been shown that the metabolism of host-derived carbon sources such as fatty acids and/or cholesterol is crucial for *M. tuberculosis* persistence in macrophages during chronic infections ([@B54]; [@B50]; [@B44]; [@B39]; [@B27]; [@B52]).

The *M. tuberculosis* complex (MTBC) is characterized by 99,95% sequence similarity at the nucleotide level and a strictly clonal population structure ([@B7]). Continuous advances in developing biological tools and reagents have facilitated genetic manipulation of the MTBC ([@B5]; [@B46]). These advances, in combination with the availability of whole genome sequences of multiple strains of members of the MTBC^[2](#fn02){ref-type="fn"}^ have allowed for the study of the contribution of individual genes to the *M. tuberculosis* pathogenicity, including those related to dormancy, the status of the bacilli during LTBI ([@B22]). One of the *in vitro* conditions required to mimic the dormant state is the stationary phase of growth in the presence of a lipid environment ([@B51]).

Transposon mutagenesis is a classical procedure to study gene-function of bacteria under a global perspective ([@B33]; [@B32]). In addition, genetic fusions have provided an important means of analyzing basic biological systems from the earliest times of molecular genetics. The basic principle of the genetic fusion approach was to put an assayable gene product under the control of another gene or promoter of interest (named reporter) thus supplying a means to monitor its expression. In this work, we have studied the potential mutagenicity supplied by a transposon that includes a promoter-less *gfp* gene ("*g*reen *f*luorescent *p*rotein") as a reporter gene.

The GFP from the jellyfish *Aequorea victoria* has been extensively used as a useful marker in studies of various biological processes ([@B18]; [@B56]). GFP is a 238-amino-acid-long protein encoded by the *gfp* gene ([@B47]). When excited by blue light at a wavelength of 395 nm, the protein emits green light that can be observed *in vivo* since no substrates or cofactors are needed for the unique post-translational modification that generates the fluorescent chromophore ([@B13]). GFP has been successfully expressed in a wide range of organisms such as the nematode *Caenorhabditis elegans* ([@B10]), the small fly *Drosophila* ([@B57]; [@B3]), and pathogenic mycobacteria ([@B21]). Modified transposons containing truncated reporter genes could be useful to identify promoters and study gene expression in mycobacteria. The transposons Tn*5367* and Tn*5368* contain IS*1096* ([@B12]) and both showed to be active in *M. bovis* BCG generating random insertions and giving rise to a set of auxotrophic mutants ([@B37]). These transposons have also been active in several strains of *M. tuberculosis* ([@B5]; [@B46]).

In the present work, we describe the construction of an IS*1096*-derivative transposon harboring the reporter *gfp* gene and its delivering system using a thermo/sucrose sensitive mycobacterial plasmid. This transposon was checked and analyzed in the slow-growing non-pathogen *M. bovis* BCG, belonging to MTBC, which can be manipulated and results can be extrapolated to *M*. *tuberculosis*. Using flow cytometry, we were able to differentiate populations of fluorescent mycobacteria. Applying this procedure, we isolated the *M. bovis* BCG_2177c::Tn*gfp* (BCG-Tn) a mutant with high fluorescence at stationary growth phase. The targeted gene, BCG_2177c, a homologous of Rv2160A of *M. tuberculosis*, has been previously identified as a putative member of the TetR-family of transcriptional regulators ([@B4]) and members of this family have been associated with the regulation of genes involved in cholesterol metabolism ([@B9]; [@B58]). Furthermore, phenotypic and genotypic characterization of the mutant in this work supports the involvement of this gene in the metabolism of cholesterol in *M. bovis* BCG.

Materials and Methods {#s1}
=====================

Bacterial Strains, Plasmids, and Growth Conditions
--------------------------------------------------

The bacterial strains and plasmids used in this study are listed in **Table [1](#T1){ref-type="table"}**. *E. coli* XL1 was used for cloning and plasmid propagation purposes and was cultured on solid or liquid Luria-Bertani medium. *M. bovis* BCG Pasteur 1173P2 (BCGwt) and *M. bovis* BCG_2177::Tn*gfp* (BCG-Tn) strains were routinely grown in 7H9 Middlebrook medium supplemented with 10% ADC and 0.05% Tween 80 or 7H10 Middlebrook medium supplemented with 10% OADC. When required, kanamycin (20 μg/ml), hygromycin (50 mg/ml), and sucrose (2%) were added to the growth medium. To study the involvement of the BCG_2177c (specific-targeted loci and TetR-like gene) in mycobacterial cholesterol catabolism, BCGwt and BCG-Tn were grown in Dubos broth (Difco^TM^) supplemented with 10% ADC to reach an optical density of 0.5 at 600 nm (OD~600~). This culture was used (1:10 dilution) to inoculate (i) Dubos broth base (without glycerol; BD Difco) containing 0.5% bovine serum albumin (BSA; fraction V, Sigma) and supplemented with 0.01% cholesterol \[a 5% cholesterol stock was obtained by dissolving the sterol in 1:1 (v/v) tyloxapol-ethanol mixture, followed by heating for 5 min at 80°C\], or (ii) Dubos medium with 10% ADC enrichment. Cultures were grown with agitation at 200 rpm at 37°C, and growth was monitored by measuring the OD~600~ and colony forming units per ml (CFU/ml).

###### 

Characteristics of bacterial strains and plasmids used in this study.

  Strains                  Characteristics                                Reference/Source
  ------------------------ ---------------------------------------------- ------------------------------
  *E. coli* XL1            recA1 laclq lacZΔM15T*v*10                     [@B53]
  *M. bovis* BCG Pasteur   Vaccine strain 1173P2                          Institute Pasteur Collection
  **Plasmids**                                                            
  pBlueScript SK           Polylinker in lacZ gene and Amp^R^             Stratagene
  pPR27                    Ts, ori myco, *sac*B gene                      [@B46]
  pKEN-mut2                Vector containing *gfp* gene                   [@B15]
  pPEP1                    pBlue Script SK+*gfp* gene whithout promoter   This work
  pPEP3                    pBlue Script+ derivated of Tn*5367*            This work
  pEZ120                   pEP1 + IR                                      This work
  pEZ121                   pEZ120 + frag SpeI of pEP3                     This work
  pEZ123                   pPR27 XbaI + Tn*gfp*                           This work

Introduction of Tn*gfp* in *M. bovis* BCG and Construction of Mutant Library
----------------------------------------------------------------------------

To produce insertion mutants, pEZ123 was introduced into *M. bovis* BCG by electroporation ([@B45]). Cells were grown in plates with kanamycin at 32°C. Then single colonies were grown in broth at 32°C to allow transposition and subsequently plated on kanamycin- (selecting transposon presence) and sucrose-containing medium plates at 39°C, which are conditions not permissive for plasmid replication ([@B46]), allowing us to obtain the transposition mutants.

Analysis of Mutants
-------------------

The colonies that survived at 39°C on plates with sucrose and kanamycin were analyzed in order to detect transposition events. Mutant DNA digested with *BamH*I enzyme generates an internal fragment of the transposon, equal for all mutants, and two variable fragments depending on the region where the transposon was inserted (**Figure [2A](#F2){ref-type="fig"}**). Some colonies of *M. bovis* BCG were analyzed by Southern-blot (**Figure [2B](#F2){ref-type="fig"}**) and Ligation-Mediated PCR (LMPCR; [@B48]).

All DNA manipulations, restriction enzyme digestions, agarose gel electrophoresis and Southern hybridizations were performed following standard procedures ([@B53]).

Analysis of the Mutant Library by Flow Cytometry
------------------------------------------------

The mutant libraries of *M. bovis* BCG were grown up at exponential phase, harvested by centrifugation, washed with PBS and resuspended in the same buffer. The bacterial suspensions were analyzed by flow cytometry (Coulter Epic "Elite"). Approximately 10.000 individual events were excited at 488 nm prior analysis.

Isolation of *M. bovis* BCG Mutants Using Fluorescence Activated Cell Sorter (FACS)
-----------------------------------------------------------------------------------

To identify mycobacterial genes putatively involved in dormancy, the different pools of colonies from the *M. bovis* BCG::Tn*gfp* library were grown up to stationary phase, then flow cytometry was used to sort out cells by fluorescence emission. Bacteria from the *M. bovis* BCG::Tn*gfp* library were analyzed and sorted. After growth in 7H9 medium to stationary phase, BCG::Tn*gfp* cells were harvested and washed two times in 1X PBS. After the final wash bacteria pellets were resuspended in PBS (approx. 10^6^ bacteria/ml) and analyzed by FACS (Coulter Epics Elite sorter. Hielary Fl, USA). To do so, the pellet of bacteria was excited with 488-nm laser and 530 nm was applied for detection. Up to 3000 cells per second of sorting was used. One cycle of flow cytometric cell sorting was performed to select bacteria showing high levels of fluorescence. Bacteria exhibiting high levels of fluorescence were collected and were plated directly on 7H10 solid medium containing kanamycin to recover individual clones.

Different colonies were re-isolated and analyzed by LMPCR ([@B48]) to identify transposon insertion sites.

Location of Tn*gfp* Insertion Sites
-----------------------------------

In order to study Tn*gfp* insertion sites LMPCR was used according to the protocol described by [@B48]. This technique allowed the amplification of both ends of the transposon. Briefly, the DNA was digested with the *Sal*I enzyme, the fragments of DNA were ligated with an adapter Sal, containing Salgd and Salpt sequences (**Table [2A](#T2){ref-type="table"}**), and the resulting template was then digested with SalI. The PCR was performed using IS2 and gfp1 primers (specific for Tn*gfp* and directed outward) and the common linker primer Salgd (**Table [2A](#T2){ref-type="table"}**). DNA was denatured by incubating the mixture at 95°C for 5 min. Amplification was achieved using 35 cycles of PCR (95°C for 30 s, specific annealing temperature for 30 s and 72°C for 90 s), followed by a final extension at 72°C for 10 m. Amplified products were separated by standard horizontal gel electrophoresis in a 1.5% agarose gel in TBE buffer (90 mM Tris, 90 mM boric acid, and 2 mM EDTA) and were stained using ethidium bromide. PCR products were purified using the GFX^TM^ PCR DNA and Gel Band Purification kit (Amersham Pharmacia Biotech Inc.) followed by ExoSAP-IT^®^ PCR product clean up (Affymetrix).

###### 

Oligonucleotides used in this study.

  ----------------------------------------------------------------------------------------- --------------------------------------------------------------------------- --------------- ---------------
  **(A)** Oligonucleotides used for the construction and study of Tn*gfp* mutant library.                                                                                               
                                                                                                                                                                                        
  **Target**                                                                                **Oligonucleotide Sequence (5′ -- 3′)**                                     **Reference**   
                                                                                                                                                                                        
  Insertion site                                                                            Salgd: TAGCTTATTCCTCAAGGCACGAGC                                             [@B48]          
                                                                                            Salpt: TCGAGCTCGTGC                                                                         
  Tn*gfp*                                                                                   IS2: GAGGCGGCAGAAAGTCGTCAGGTCAG                                             This work       
                                                                                            gfp1: TCCTTCTTAAATCTAGGGCTGCAG                                                              
  Inverted Repeat (IR)                                                                      IR1: AAGCTTTCTAGAGGCTCTTCGCACTTGACGGTGTAGAGACGATCAGCTG CTTTCGCGCTGAAGCTT    This work       
                                                                                            IR2: TGCAGATCACAGCGGAAAGCAGCTGATCGTCTCTACACCGTCAAGTGCGAAGAGCC TCTAGAAGCTT                   
                                                                                                                                                                                        
  **(B)** Oligonucleotides used for Real Time quantitative PCR (RT-qPCR) experiments^∗^.                                                                                                
                                                                                                                                                                                        
  **Target**                                                                                **Oligonucleotide Sequence (5′ -- 3′)**                                     **T°C ann.**    **Reference**
                                                                                                                                                                                        
  **16S ribosomal RNA**                                                                                                                                                                 
  *rrs* (16S rDNA)                                                                          16S TB-F: ATGACGGCCTTCGGGTTGTA                                              66°C            [@B17]
                                                                                            16S TB-R: CGTATTACCGCGGCTGCTGGCAC                                                           
  **Genes**                                                                                                                                                                             
  *tgs*1 (Rv3130c)                                                                          *tgs*1-F: TTGCCACCCGCCTTCC                                                  50°C            This work
                                                                                            *tgs*1-R: TCGCCACGGTGACAACA                                                                 
  *ltp*2 (Rv3540c)                                                                          Rv3540c-F: GTATCGGGCATTCAACGAAC                                             55°C            This work
                                                                                            Rv3540c-R: GTGCGGATACGAAAACGAAT                                                             
  *yrb*E4A (Rv3501c)                                                                        Rv3501c-F: CTACGCGTTCTCGGTCTTTC                                             55°C            This work
                                                                                            Rv3501c-R: AGTATCAATTCGCGCAGTCC                                                             
  *mur*E (Rv2158c)                                                                          Rv2158c-F: CGCCTTCACCAATCTCTCC                                              55°C            This work
                                                                                            Rv2158c-R: AGTCCGGATCGAACAATGAC                                                             
  **Small RNAS**                                                                                                                                                                        
  MTS2823                                                                                   MTS2823-F: GAGAAGGTTCGGTCTCCCGAC                                            58°C            This work
                                                                                            MTS2823-R: TTACGCAGACCCGCAACACT                                                             
  MTS0997                                                                                   MTS0997-F: AAGCAGGCCCGGTTAGTGA                                              58°C            This work
                                                                                            MTS0997-R: CACCGGTACACATGGGCAGA                                                             
  *rnp*B                                                                                    rnpB-F: TTCACAGAGCAGGGTGATTG                                                62°C            This work
                                                                                            rnpB-R: CTCTTACCGCACCGTTTCAC                                                                
  ----------------------------------------------------------------------------------------- --------------------------------------------------------------------------- --------------- ---------------

∗

The sequences of

M. tuberculosis

H37Rv and

M. bovis

BCG Pasteur are identical in all the genes and genomic regions under study.

The amplified products were sequenced with the corresponding oligonucleotides using CNIO^[3](#fn03){ref-type="fn"}^ service and further checked for homology at Tuberculist^[4](#fn04){ref-type="fn"}^, Bovilist^[5](#fn05){ref-type="fn"}^ and NCBI^[6](#fn06){ref-type="fn"}^ database BLAST analysis.

Microscopy Analysis
-------------------

Mycobacterial cells were recovered from Dubos medium containing either dextrose or cholesterol at days 7 and 30, and were concentrated by centrifugation. Twenty microliter of each sample were smeared on three different slides, which were stained by Ziehl--Neelsen and with either, Auramine-O (Tec-Lam SA) or Nile Red (Sigma-Aldrich), following a previously published protocol ([@B20]). Microscopy for the fluorescence-based experiments was performed with an ECLIPSE Ti-Nikon's microscope. Images were acquired using a Nikon Intensilight C-HGFI digital camera. All magnifications were carried out with a 100X oil-immersion objective.

Mycobacterial RNA Isolation
---------------------------

Total RNA was isolated from cultures at the exponential and stationary phases as previously described ([@B25]). Briefly, cultures were harvested by centrifugation and pellets were resuspended in guanidinium chloride buffer (6M guanidinium chloride, 0.1% Tween 80, 1mM 2-mercaptoethanol, 10 mM EDTA) in a proportion of 1 ml of buffer/100 ml of culture. Cells were lysed mechanically in a FastPrep (Thermo Scientific) with 150- to 200-μm glass beads (Sigma-Aldrich) by performing four lysis cycles of 15 s each at high speed (6.5 m/s). Nucleic acids were purified with phenol-chloroform-isoamylic alcohol (25:24:1), and RNA was differentially precipitated with 0.4 volume of absolute ethanol (added drop by drop).

Finally, RNA was washed three times with Trizol reagent (Invitrogen). RNA integrity was analyzed with a bioanalyzer (Agilent technologies) and quantified by spectrophotometry with a NanoDrop ND-1000 (Thermo Scientific).

qRT-PCR of Selected Genes and Non-coding RNAs
---------------------------------------------

Transcription levels of several selected targets were measured by using real-time quantitative RT-PCR. Quantification was carried out with specific primers (**Table [2B](#T2){ref-type="table"}**) and Light Cycler FastStart DNA SYBR green (Roche). Samples were subjected to 1 cycle at 95°C for 60 s (to activate the enzyme) followed by 40 cycles of amplification (denaturation at 95°C for 0 s, specific annealing temperature for 5 s, and extension at 72°C for 10 s) with a final extension at 72°C for 10 min. A melting curve analysis was performed to determine the specificity of the amplified product.

The standard curve was obtained for each pair of primers by using 10-fold dilutions of known amounts of *M. tuberculosis* H37Rv chromosomal DNA (nanograms of DNA per microliter). Threshold cycle values of each transcript quantified were interpolated to standard curve to measure the level of transcription. At least three amplifications per target were performed. Normalization of the data was performed by using 16S rRNA levels.

Results
=======

Construction of the Tn*gfp* Delivery Plasmid pEZ123
---------------------------------------------------

In order to obtain a library of mutants by transposition, containing a *gfp* gene, acting as reporter gene, an artificial transposon containing two IR of IS*1096* at both ends, was constructed as described in the Section "Materials and Methods" (**Figure [1A](#F1){ref-type="fig"}**). The transposon, named Tn*gfp* (**Figure [1B](#F1){ref-type="fig"}**), contains the *orfA* gene from Tn*5397* ([@B37]), a kanamycin-resistance gene and a promoterless copy of the gene encoding a mutated version of GFP ([@B15]). This form of GFP exhibits greater fluorescence and solubility compared to the wild- type protein. Tn*gfp* was cloned into the plasmid pPR27 ([@B46]), an *Escherichia coli*-*Mycobacterium* shuttle plasmid, which is thermosensitive and able to replicate in mycobacteria, contains the gentamicin resistance gene and contains the *sacB* gene as a counter selectable marker. The resulting deliverable vector containing Tn*gfp* was named pEZ 123 (**Figure [1B](#F1){ref-type="fig"}**).

![**Schematic diagram showing the construction of Tn*gfp* delivering system pEZ123. (A)** Construction of pEZ121 containing Tn*5367* derivative with *gfp* reporter gene (Tn*gfp*). **(B)** Map of the plasmid pEZ123 containing Tn*gfp*. This plasmid was used for the construction of the libraries of mutants of *Mycobacterium bovis* BCG. Delivering system is based on a thermosensitive and sensitive to sucrose mycobacterial plasmid. Construction is described in material and methods.](fmicb-08-00315-g001){#F1}

Tn*gfp* Mutagenesis Library in *M. bovis* BCG
---------------------------------------------

To determine the functional activity of Tn*gfp*, pEZ123 (**Figure [1B](#F1){ref-type="fig"}**) was introduced in the slow growing non-pathogenic mycobacteria *M. bovis* BCG. After growing on kanamycin and sucrose containing medium at 39°C, we selected transposition mutants. A transposon mutagenesis library with Tn*gfp* in BCG was constructed. We prepared an ordered library consisting of independent 5664 kanamycin, sucrose and thermoresistant mutants. The library was assembled into 40 pools. To verify that the transposition library was representative, some *M. bovis* BCG mutants were analyzed by digestion and then hybridized with the transposon. Mutant DNA digested with BamHI enzyme, generates an internal fragment of the transposon, equal for all mutants, and two variable fragments depending on the region where the transposon was inserted (**Figure [2A](#F2){ref-type="fig"}**). Southern blot analysis of randomly selected colonies for 11 mutants showed that each of them contained a single transposon insertion that produced a unique restriction fragment pattern (**Figure [2B](#F2){ref-type="fig"}**). We also analyzed 150 mutants from the ordered library by LMPCR technique. By sequencing the transposon flanking regions, we identified 77 different points of transposon insertion (Supplementary Table [S1](#SM6){ref-type="supplementary-material"}). The obtained locations of the transposon were plotted in the *M. bovis* BCG genome showing a distribution through the entire chromosome length (**Figure [2C](#F2){ref-type="fig"}**). Sequencing of the insertion junctions of the 77 mutants revealed that 66 (85.7%) insertions were found within ORFs and 11 were intergenic regions (Supplementary Table [S1](#SM6){ref-type="supplementary-material"}).

![**Results of the Tn*gfp* transposition.** *M. bovis* BCG mutants analyzed by enzymatic digestion and then hybridized with a transposon probe. **(A)** Mutant DNA digested with BamHI enzyme, generates an internal fragment of the transposon (1.6 Kb), equal for all mutants, and two variable fragments depending on the region in which the transposon was inserted. **(B)** Southern-Blot analysis of 11 *M. bovis* BCG mutants. The DNA of colonies that had grown at 39°C with sucrose was digested with BamHI and hybridize with the Tn*gfp* like probe. Lane 1, DNA from *M. bovis* BCG; Lane 2, Plasmid pEZ123; Lanes B1--B12 different mutants of *M. bovis* BCG. **(C)** Distribution of Tn*gfp* through the *M. bovis* BCG genome. The obtained locations of the transposon were plotted in *M. bovis* BCG genome.](fmicb-08-00315-g002){#F2}

Flow Cytometry Analysis of the Tn*gfp M. bovis* BCG Libraries
-------------------------------------------------------------

To determine if the *M. bovis* BCG mutant library was useful to differentiate populations of fluorescent bacteria, the library was analyzed by flow cytometry. Only 3.65% of the *M. bovis* BCG mutants in the library showed detectable fluorescence levels (**Supplementary Figure [S1A](#SM1){ref-type="supplementary-material"}**).

Aiming to select transposition mutants putatively involved in dormancy, further analyses were performed to detect *M. bovis* BCG::Tn*gfp* cells exhibiting high levels of fluorescence at stationary phase by using FACS. Up to 23 colonies were re-isolated and analyzed by LMPCR to localize the transposon insertion site. From these, only mutants where the orientation of *gfp* and the neighbor gene was the same were selected. One of those mutants showed GFP expression level more than 20-fold compared to other mutants. GFP production was maximal at stationary phase (**Supplementary Figure [S1B](#SM1){ref-type="supplementary-material"}**). This mutant was identified as carrying the transposon inserted 56 nucleotides inside from start codon of the 2177c gene of *M. bovis* BCG, which is part of an operon located immediately upstream of the *dcw* operon (**Figure [3](#F3){ref-type="fig"}**), the last known to be involved in cell division and cell wall formation in *M. tuberculosis* ([@B40]).

![**Location of Tngfp in BCG_2177c gene in the *M. bovis* BCG genome.** BCG_2177c gene is located upstream from the division cell wall gene cluster (*dcw*). The insertion of Tngfp was in the same orientation that replication *dcw* genes. Gene members of the *dcw* operon as well as genes of the same operon that BCG_2177c were indicated.](fmicb-08-00315-g003){#F3}

BCG_2177c has been reported to be homologous to Rv2160A of *M. tuberculosis*, identified as a member of the TetR-family of transcriptional regulators, which have been related to the regulation of genes involved in cholesterol metabolism ([@B9]).

Growth of BCG-Tn in Cholesterol
-------------------------------

In order to determine the influence of cholesterol on the growth of (BCG-Tn), we cultured BCGwt and its mutant in a medium supplemented with cholesterol as a sole carbon source. Growth in cholesterol was compared to growth in dextrose (control medium). We found similar growth profiles measured by CFUs for those mycobacteria independent of the carbon source used (**Supplementary Figure [S2B](#SM2){ref-type="supplementary-material"}**). Some differences were found in the growth profiles measured by OD. For example, the exponential phase slopes of the wild type strain and its corresponding mutant were very similar in the presence of cholesterol (**Supplementary Figure [S2A](#SM2){ref-type="supplementary-material"}**) and both strains reached the stationary phase at the same time (day 4). In contrast, when both mycobacteria were grown in the presence of dextrose, BCG-Tn showed an exponential phase delay, compared with wild type, and it approximately reached only half of the cell density (in relation to wild type) at the end of stationary phase. The influence of cell aggregation in the OD results cannot be discarded.

The effect of cholesterol on the microscopic morphology of BCG wild type and BCG-Tn mutant was analyzed at exponential and stationary growth phases. Both strains were tested and their growth in dextrose and cholesterol were also compared (**Figure [4](#F4){ref-type="fig"}** and **Supplementary Figure [S3](#SM3){ref-type="supplementary-material"}**). When both strains were cultured in the presence of cholesterol, an accumulation in the lipid content was shown, by Nile Red stain, compared to the cultures in dextrose. During the exponential phase of growth, no differences were detected comparing wild-type and mutant by Ziehl--Neelsen, Auramine or Red Nile stains (**Supplementary Figure [S3](#SM3){ref-type="supplementary-material"}**). In contrast, strong cord formation was identified at the stationary phase when the mutant was grown in cholesterol (**Figures [4J--L](#F4){ref-type="fig"}**). In addition, cell aggregation was also found in the wild-type growing in cholesterol at stationary phase (**Figures [4D--F](#F4){ref-type="fig"}**). The aggregates or cords were not present in stationary phase when wild-type and mutant were grown in dextrose (**Figures [4A--C,G,H](#F4){ref-type="fig"}**).

![**Morphological changes of BGC wt and BCG-Tn during stationary phase in the presence of different carbon sources.** Morphological changes in stationary phase of mycobacterial cultures after growth in the presence of dextrose **(A--C)** and **(G--I)** or cholesterol **(D--F)** and **(J--L)** as carbon sources. BCGwt **(A--F)** or BCG-Tn **(G--L)** cells were harvested from the corresponding cultures and stained by Ziehl--Neelsen **(A,D,G,J)** or with Auramine **(B,E,H,K)** or Red Nile **(C,F,I,L)** the two last by fluorescent microscopy. Cord-like structures are observed in **(J--L)** panels, corresponding to stationary phase of the mutant growing in cholesterol. All magnifications were carried out with the 100X oil immersion objective.](fmicb-08-00315-g004){#F4}

Gene Expression of *M. bovis* BCG-Tn in Cholesterol
---------------------------------------------------

To gain insights into the influence of the transposon on gene expression related to cholesterol metabolism, several genes were quantitatively analyzed from cultures recovered at exponential and stationary phases of growth. Genes related to cholesterol metabolism such as *ltp*2, a probable lipid transfer protein, and *yrb*E4A, a possible ABC transporter, both putatively involved in cholesterol intake, were studied. Apart from *tgs*1, a central gene in the lipid metabolism and *mur*E, the gene leading the *dcw* operon located downstream of the transposon insertion was also studied. Comparisons were made between BCGwt and BCG-Tn growing with and without cholesterol as a sole carbon source. Moreover, cultures were recovered at exponential and stationary phases of growth in each culture condition.

**Figure [5](#F5){ref-type="fig"}** showed the ratio of gene expression comparing mutant versus wt bacteria. The level of expression of *mur*E was higher in the mutant, particularly when bacilli grew in cholesterol and during exponential phase. Genes related to cholesterol metabolism, namely *ltp*2 and *yrb*E4A, also showed higher expression in the mutant compared to the wt when bacteria grew with cholesterol, with a more marked increase observed during stationary phase (**Figure [5A](#F5){ref-type="fig"}**). These results could suggest a repressor activity of the *tet*R-like gene over those genes, being that activity enhanced in the presence of cholesterol. On the contrary, the level of expression of *tgs*1 was lower in dextrose and stationary phase in the mutant compared to the wt. This gene was undetectable in the mutant when the bacteria grew in cholesterol (**Figure [5A](#F5){ref-type="fig"}**).

![**Differential expression of selected genes and ncRNA in *M. bovis* BCG (BCGwt and BCG-Tn).** Level of expression of BCG wt versus BCG-Tn of **(A)** *murE, tgs*1, *ltp*2, and *yrb*E4A genes; and **(B)** MTS2823, MTS0997, and *rnp*B ncRNAs. Log rate of number of copies/ng of the mutant BCG-Tn and BCGwt were calculated in different conditions of culture (Dextrose: DEX; Cholesterol: CHOL) and growing phases (Exponential: EXP; Stationary: ST). The data were normalized with the expression of *rrs* gene coding for 16S-rRNA. UDL, under detection level. Complete set of data is showed in **Supplementary Figures [S4](#SM4){ref-type="supplementary-material"}, [S5](#SM5){ref-type="supplementary-material"}**.](fmicb-08-00315-g005){#F5}

Detection of non-coding RNAs was also performed (**Figure [5B](#F5){ref-type="fig"}**). With few exceptions, the three non-coding targets showed higher expression in the mutant compared to the wt, both in dextrose as well as in cholesterol. The non-coding *rnp*B, involved in tRNA maturation was 400-fold more expressed in the mutant during exponential phase in cholesterol (**Figure [5B](#F5){ref-type="fig"}**).

The complete set of qRT-PCR normalized data of the targeted genes and the targeted non-coding RNAs, are presented in **Supplementary Figures [S4](#SM4){ref-type="supplementary-material"}, [S5](#SM5){ref-type="supplementary-material"}**, respectively.

Discussion
==========

Since transposition was first demonstrated in fast growing mycobacteria with IS*6100* ([@B35]), other mycobacterial ISs, not presents in *M. tuberculosis*, have been demonstrated to be active in mycobacteria ([@B36]). Transposons derived from the *M. smegmatis* insertion sequence IS*1096* ([@B12]) were modified for its use in slow-growing mycobacteria by the insertion of a kanamycin resistance cassette showing to be active in *M. bovis* BCG and in several strains of *M. tuberculosis* and *M. paratuberculosis* ([@B37]; [@B5]; [@B46]; [@B29]). After those developments, transposon mutagenesis was available in mycobacteria allowing for the preparation of transposon-mutant libraries, in such a way that phenotypic screening on a large scale could be undertaken, including the study of genes required for pathogen adaptation to a host by using signature-tagged mutagenesis ([@B8]; [@B16]).

The use of fusions with reporter genes might enable the identification of genes that were differently expressed under specific conditions ([@B34]; [@B19]). The *gfp* gene is a useful reporter for *in vivo* studies because no substrate is required for the detection of its fluorescent product ([@B56]). Previous studies allowed the detection of promoters through detection of an increase expression of *gfp* in *M. tuberculosis* and *M. bovis* BCG ([@B55]) or *M. marinum* ([@B6]) growing inside macrophages. In our work, intracellular levels of GFP were found to be 2--20 times higher than that found in previous *in vitro* cultures of those mycobacteria performed in the laboratory (data not shown).

In this work, we have developed a new artificial transposon suitable to generate expression libraries of the GFP fluorescent protein in mycobacteria. We have tested the transposition driven by Tn*gfp* as a rapid method to generate multiple insertions into the chromosome of *M. bovis* BCG, and we constructed a comprehensive bank of 5664 insertion mutants using a new transposon mutagenesis system. Moreover, analysis by flow cytometry provided high sensitivity allowing the detection of fluorescent bacteria, even with a single copy of *gfp* per genome, therefore it was useful for the screening of *M. bovis* BCG transposon mutant libraries under different conditions.

A wide range of different insertion sites were identified in *M. bovis* BCG (up to 77/150 clones). When, we analyzed the transposon insertion points of these mutants we observed that transposition occurred randomly (**Figure [2C](#F2){ref-type="fig"}** and Supplementary Table [S1](#SM6){ref-type="supplementary-material"}). No consensus sequence was identified as a target for this transposon. Remarkably, 85,7% of the insertions happened in coding regions. The suitability of the procedure to generate a representative library could be inferred taking into consideration that: (1) 91% of *M. tuberculosis* genome corresponds to open reading frames ([@B14]); and (2) when the transposon disrupts an essential gene such a mutant will not be obtained. In addition, genes interrupted by Tn*gfp* are distributed among the different functional categories in the BCG genome, similarly to the proportional distribution in the genome of *M. tuberculosis*^[7](#fn07){ref-type="fn"}^. Other studies of transposition *in vivo* (using IS*6110)* reported only 50% transposon insertion within coding regions in *M. tuberculosis* and in *M. bovis* strains ([@B38]; [@B42]; [@B1]).

In searching for transposition events in loci putatively related to dormancy, the fluorescent level of *M. bovis* BCG::Tn*gfp* cells were studied in stationary phase and analyzed by flow cytometry. Using this procedure, a mutant targeting the gene BCG_2177c (named BCG-Tn) was detected. This transposon mutant showed approximately 20 times higher fluorescent levels at stationary phase compared to other mutants tested (data not shown).

BCG_2177c is homologous to *M. tuberculosis* Rv2160A, a gene identified in *M. tuberculosis* with similarities to the TetR-family of transcriptional regulators. TetR is a large family of transcriptional regulators known to be involved in many metabolic routes in bacteria ([@B49]). Some members of this family were involved in the metabolism of cholesterol ([@B31]). The genome of *M. tuberculosis* encodes for a high number of genes involved in the catabolism of cholesterol ([@B43]), a main carbon source of the tubercle bacilli during infection, including latent infection ([@B39]).

To gain insights into the role that BCG_2177c could play in *M. bovis* BCG, BCG-Tn mutant and BCG *wt* were studied in more detail during their growth in cholesterol. Growth curves of both bacteria in cholesterol or dextrose as main carbon sources showed an impaired growth in dextrose of the mutant compared to *wt* (**Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}**). On the other hand, a particular morphological change was observed in the mutant during stationary phase in cholesterol. Under this last condition, the BCG-Tn bacilli showed strong cord formation (**Figures [4J--L](#F4){ref-type="fig"}**), which was not observed in the mutant or in the *wt* in any other condition. These findings suggest changes in the cell envelope of the bacteria possibly related to the targeted gene.

Notable was the increased level of the nc RNA, namely rnpB, in the mutant, during exponential phase growth in cholesterol (**Figure [5](#F5){ref-type="fig"}**). This non-coding RNA is a component of the RNase P and participates in the maturation of tRNAs ([@B30]). The involvement of tRNAs in changes at the cell wall level ([@B23]) suggests that a modification of such cell structures during the adaptation of the mutant to growth in cholesterol could putatively be related with the phenotypic changes of the mutant in stationary phase detected by acid-fast and fluorescent staining (**Figures [4J--L](#F4){ref-type="fig"}**). Interestingly, this ncRNA seems to be essential for *M. tuberculosis* when the bacillus grows in cholesterol ([@B26]).

To further analyze the influence of cholesterol in more detail, the transcriptomic patterns of selected genomic regions known to have some role in the infection of *M. tuberculosis* ([@B2]; [@B39]) were studied. This was carried out in all four culture conditions. Results showed that genes related to cholesterol metabolism (*ltp*2 and *yrb*E4A) have roughly similar expression levels between mutant and *wt* in dextrose, but their levels of expression increased in the mutant during growth in cholesterol, mainly at stationary phase (**Figure [5A](#F5){ref-type="fig"}**). These results suggested a putative repressor activity of BCG_2177c on those genes in the presence of cholesterol. It has been shown that *yrb*E4 expression is regulated by a TetR-family member (KstR) in *M. tuberculosis* ([@B43]). The expression level of the *yrb*E4 is not affected when *M. tuberculosis* is cultured in dextrose^[8](#fn08){ref-type="fn"}^; unfortunately, this effect is unknown in *M. tuberculosis* growing in cholesterol. Our results suggested that BCG_2177c could play a similar role in *M. bovis* BCG, and that influence appeared to be enhanced during growth in cholesterol.

The participation of the gene *mur*E in the synthesis of the peptide-glycan, suggested a higher level of its expression when bacteria grows faster. As expected, according to **Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}**, a higher level of expression of this gene was detected in cholesterol compared to dextrose in both strains. Compared to BCG *wt*, the level of expression detected for *mur*E in the mutant BCG-Tn was high in all conditions, except dextrose at exponential phase (**Figure [5A](#F5){ref-type="fig"}**), a condition that causes an impaired growth of the mutant (**Supplementary Figure [S2](#SM2){ref-type="supplementary-material"}**). Whether this result was a direct consequence of the transposition event or not requires further studies.

An unexpected result was found for the gene *tgs*1, a main gene involved in dormancy that participates in the synthesis of triacylglycerol in *M. tuberculosis*. Comparing mutant and *wt*, this gene was similarly expressed in both strains during growth in dextrose, although it showed a slight level of increase in exponential phase in the mutant. However, its expression was undetectable in the mutant when cholesterol was used as a carbon source (**Figure [5](#F5){ref-type="fig"}**). Our results showed that the expression of *tgs*1 ceased when BCG_2177c was truncated after transposition, thus suggesting a direct or indirect participation of the BCG_2177c gene in the activation of *tgs*1 expression in *M. bovis* BCG during growth in cholesterol.

Finally, the expression of two other nc-RNAs was also analyzed in the mutant BCG-Tn and BCG *wt* under the four conditions studied (**Figure [5B](#F5){ref-type="fig"}**). The data showed a higher level of expression of the nc-RNAs in the mutant, when bacteria grew in cholesterol, particularly at stationary growth phase. This result was also found when *M. tuberculosis* was grown in long chain-fatty acids as a sole carbon source ([@B51]) thus suggesting a role of these two nc-RNAs during latent infection, a situation in which lipids, including cholesterol, seem to play an essential role in *M. tuberculosis*. Our results showed that BCG_2177c could play some role during a similar process in *M. bovis* BCG.

As described in this work, the transposon mutagenesis system has showed to be an excellent procedure in the study of gene function, even in fastidious bacteria such as mycobacteria. Our transposon Tn*gfp* was shown to be active also in other mycobacteria, from the main pathogen *M. tuberculosis* to the saprophyte *M. smegmatis*, therefore this methodology could be putatively applied to the study of gene function in other members of the genus. Moreover, by application of the Tn-seq technique, this transposon system represents a valuable tool for a wider study of gene function in the genus.

Finally, limitations of the system exist, such as the lack of detection of low-level promoters or the lost of strong promoters due to deleterious effect of GFP accumulation. Likewise, the involvement of other regulators that may indirectly influence the changes detected cannot be discarded.

In summary, to the best of our knowledge, this work showed for the first time the usefulness of a transposon mutant library prepared with the promoterless gfp gene. We have showed that the novel transposon mutagenesis system developed in this study is a useful tool to analyze functional activity of targeted genes in *M. bovis* BCG. While further characterization is still required, our work also proposes the direct or indirect involvement of BCG_2177c gene in cholesterol metabolism of this vaccine strain, suggesting a role of this putative TetR gene during the survival of the strain in the human host, a cholesterol-enriched environment.
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**GFP expression of the *M. bovis* BCG library and *M. bovis* BCG-Tn. (A)** Flow cytometry analysis of the library of *M. bovis* BCG mutants at logarithmic phase. A total of 3.65% of the mutants showed detectable fluorescence level. **(B)** Histograms obtained by flow cytometry at four different points of the growth curve of the mutant *M. bovis* BCG-Tn. The expression level of gfp at stationary phase (days 32 and 64 of growth) was much higher than at logarithmic phase (days 2 and 3).
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***Mycobacterium bovis* BCGwt and *M. bovis* BCG-Tn growth curve in the presence of dextrose (DEX) or cholesterol (CHOL) as carbon sources. (A)** Optical density at 600 nm; **(B)** Colony forming units.
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**Morphological changes of BGC wt and BCG-Tn during exponential phase in the presence of different carbon sources.** Morphological changes in exponential phase of mycobacterial cultures after growth in the presence of dextrose **(A--C)** and **(G--I)** or colesterol **(D--F)** and **(J--L)** as carbon sources. BCGwt **(A--F)** or BCG-Tn **(G--L)** cells were harvested from the corresponding culture and stained by Ziehl--Neelsen **(A,D,G,J)** or with Auramine **(B,E,H,K)** or Red Nile **(C,F,I,L)** the two last by fluorescent microscopy.
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**Levels of expression of genes in *M. bovis* BCGwt and *M. bovis* BCG-Tn normalized with 16S rRNA.** Levels of expression in the presence of dextrose (DEX) or cholesterol (CHOL) during exponential (EXP) and stationary (ST) phases of growth. Mean values of at least three amplifications per target and corresponding error bars are indicated.
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**Levels of expression of ncRNAs in *M. bovis* BCGwt and *M. bovis* BCG-Tn normalized with 16S rRNA.** Levels of expression in the presence of dextrose (DEX) or cholesterol (CHOL) during exponential (EXP) and stationary (ST) phases of growth. Mean values of at least three amplifications per target and corresponding error bars are indicated.
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